ScioScientific LLC

Pfizer has reported encouraging results for its investigational lung cancer therapy, adding to ongoing efforts to develop more effective treatments for one of the world's leading causes of cancer deaths. Here's more.

Closely watched Pfizer lung cancer drug falls short in clinical trial Pfizer said an experimental drug it hoped could replace a widely used chemotherapy in one of the most common forms of lung cancer fell short in a clinical trial.

The weight-loss drug market continues to evolve rapidly, with new data and competition shaping the next phase of obesity treatment development and access. Here's more on this.

What’s next for GLP-1 weight loss drugs? What’s next for GLP-1 weight loss drugs? Alex Hogan explores on the new episode of STATus Report. Watch now.